[Table/Fig-7]:
Study group | Control group | p- value | p-value after adjusting for baseline using ANCOVA | Effect size | |
---|---|---|---|---|---|
FMAS1 | |||||
Mean ± SD | 48.1 ± 5.42 | 45.4 ± 3.42 | 0.0247 | <.0001 | 0.2870 |
Median | 49 | 46 | |||
Min-Max | 30-56 | 40-51 | |||
AOUS1 | |||||
Mean ± SD | 18.07 ± 2.5 | 16.87 ± 2.52 | 0.0691 | 0.0007 | 0.1830 |
Median | 18 | 17 | |||
Min-Max | 13-23 | 13-21 | |||
QOUS1 | |||||
Mean ± SD | 16.8 ± 2.73 | 15.5 ± 2.11 | 0.0438 | 0.0015 | 0.1640 |
Median | 16.5 | 15.5 | |||
Min-Max | 11-22 | 12-20 | |||
FMAS3 | |||||
Mean ± SD | 50.57 ± 4.97 | 46.93 ± 3.41 | 0.0017 | <.0001 | 0.4240 |
Median | 52 | 47.5 | |||
Min-Max | 33-57 | 41-52 | |||
AOUS3 | |||||
Mean ± SD | 19.7 ± 2.64 | 18.03 ± 2.77 | 0.0204 | 0.0003 | 0.2030 |
Median | 19 | 18 | |||
Min-Max | 15-25 | 11-23 | |||
QOUS3 | |||||
Mean ± SD | 18.2 ± 2.67 | 16.73 ± 2.46 | 0.0310 | 0.0008 | 0.1790 |
Median | 18.5 | 17 | |||
Min-Max | 14-23 | 12-21 |
After applying ANCOVA taking baseline as covariate there is significant difference in values of FMAS, AOUS and QOUS between study group and control group at 1 month and 3 months.